Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Commentary Volume 5 Issue 12

Pink October Like No Other: When PINK Turns into Black

Rebecca Badawi1, Lina El Murr2 and Georges El Hachem3*

1Internal Medicine Resident, Department of Internal Medicine, Saint George Hospital University Medical Center, Beirut, Lebanon

2Hematology and Medical Oncology Fellow, Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center, Beirut, Lebanon

3Hematologist and Medical Oncologist, Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center and Assistant Professor of Clinical Medicine, University of Balamand, Lebanon

*Corresponding Author: Georges El Hachem, Hematologist and Medical Oncologist, Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center and Assistant Professor of Clinical Medicine, University of Balamand, Lebanon.

Received: November 10, 2021; Published: November 25, 2021

Abstract

In 1985, the American Cancer Society declared October as National Breast Cancer Awareness Month. In the same year, the incidence of breast cancer in females was estimated at 719,000 ranking it the first among all cause cancer in women [1]. Since then, it has increased to 2,261,419 cases in 2020 [2]. This raise in incidence is attributed to improved awareness which lead to increased screening. In addition, the 5-year survival rate improved from an estimated 74 percent in 1985 to 90 percent in 2017, a consequence of early detection and advances in treatment modalities [3,4].

References

  1. Boyle P. “Global burden of cancer”. Lancet 349 (1997): 23-26.
  2. Sung Hyuna., et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA: A Cancer Journal for Clinicians3 (2021): 209-249.
  3. American Cancer Society. “Breast Cancer Facts and Figures 2019-2020”. Atlanta: American Cancer Society, Inc. (2019).
  4. Michel P Coleman., et al. “Cancer survival in five continents: a worldwide population-based study (CONCORD)”. The Lancet Oncology8 (2008): 730-756.
  5. Elias F., et al. “Effectiveness of breast cancer screening campaigns from 2012 to 2017 by analysis of stage at diagnosis, Lebanon”. Eastern Mediterranean Health Journal 6 (2021): 580-586.
  6. El Hachem G., et al. “Oncology in Lebanon: From Shortage of Drugs to Shortage of Lives". Acta Scientific Cancer Biology9 (2021): 26-27.

Citation

Citation: Georges El Hachem., et al. “Pink October Like No Other: When PINK Turns into Black". Acta Scientific Cancer Biology 5.12 (2021): 17-18.

Copyright

Copyright: © 2021 Georges El Hachem., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is August 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US